Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L SCHNEIDER

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Family Practice|August 1, 1983
Prevalence of vitamin and mineral supplement use in the elderlyC L Schneider, D J Nordlund
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 13, 2000
Cholesteryl ester enrichment of plasma low-density lipoproteins in hamsters fed cereal-based diets containing cholesterolT P Carr, G Cai, J Y Lee, et al.
Clinical and Experimental Immunology|November 6, 2012
Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasisC Lochmatter, C L Schneider, K Ingram, et al.
The Journal of Biological Chemistry|April 5, 2000
Caspase inhibitor P35 and inhibitor of apoptosis Op-IAP block in vivo proteolytic activation of an effector caspase at different stepsD J LaCount, S F Hanson, C L Schneider, et al.
The Journal of Nutrition|May 10, 2000
Dietary stearic acid reduces cholesterol absorption and increases endogenous cholesterol excretion in hamsters fed cereal-based dietsC L Schneider, R L Cowles, C L Stuefer-Powell, et al.
The EMBO Journal|April 16, 1999
Crystal structure of baculovirus P35: role of a novel reactive site loop in apoptotic caspase inhibitionA J Fisher, W d Cruz, S J Zoog, et al.
Journal of Virology|December 1, 1992
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cellsR L LaFemina, C L Schneider, H L Robbins, et al.
The Journal of Infectious Diseases|May 1, 1995
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitorS Staszewski, F E Massari, A Kober, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 18, 2026
Management of insomnia in inpatient psychiatric care: a clinical practice evaluationC L Schneider, M Anselin, E Hertenstein, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsV W Byrnes, E A Emini, W A Schleif, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Family Practice|August 1, 1983
Prevalence of vitamin and mineral supplement use in the elderlyC L Schneider, D J Nordlund
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 13, 2000
Cholesteryl ester enrichment of plasma low-density lipoproteins in hamsters fed cereal-based diets containing cholesterolT P Carr, G Cai, J Y Lee, et al.
Clinical and Experimental Immunology|November 6, 2012
Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasisC Lochmatter, C L Schneider, K Ingram, et al.
The Journal of Biological Chemistry|April 5, 2000
Caspase inhibitor P35 and inhibitor of apoptosis Op-IAP block in vivo proteolytic activation of an effector caspase at different stepsD J LaCount, S F Hanson, C L Schneider, et al.
The Journal of Nutrition|May 10, 2000
Dietary stearic acid reduces cholesterol absorption and increases endogenous cholesterol excretion in hamsters fed cereal-based dietsC L Schneider, R L Cowles, C L Stuefer-Powell, et al.
The EMBO Journal|April 16, 1999
Crystal structure of baculovirus P35: role of a novel reactive site loop in apoptotic caspase inhibitionA J Fisher, W d Cruz, S J Zoog, et al.
Journal of Virology|December 1, 1992
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cellsR L LaFemina, C L Schneider, H L Robbins, et al.
The Journal of Infectious Diseases|May 1, 1995
Combination therapy with zidovudine prevents selection of human immunodeficiency virus type 1 variants expressing high-level resistance to L-697,661, a nonnucleoside reverse transcriptase inhibitorS Staszewski, F E Massari, A Kober, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 18, 2026
Management of insomnia in inpatient psychiatric care: a clinical practice evaluationC L Schneider, M Anselin, E Hertenstein, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsV W Byrnes, E A Emini, W A Schleif, et al.
Pageof 2